Gary J. Nabel Candel Therapeutics, Inc. (CADL) insider trading activity

CADL Quotes by TradingView

Gary J. Nabel is of Candel Therapeutics, Inc.. Currently has a direct ownership of 5,353 shares of CADL, which is worth approximately $36,668. The most recent transaction as insider was on Jun 25, 2025, when has been sold 5,353 shares (Common Stock) at a price of $4.67 per share, resulting in proceeds of $24,998. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 5.35K
n/a 3M change
n/a 12M change
Total Value Held $36,668

Gary J. Nabel Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 25 2025
BUY
Grant, award, or other acquisition
$24,998 $4.67 p/Share
5,353 Added 50.0%
5,353 Common Stock

Also insider at

SIGA
SIGA TECHNOLOGIES INC Healthcare
OPK
OPKO HEALTH, INC. Healthcare
Chief Innovation Officer
GJN

Gary J. Nabel

Needham, MA

Track Institutional and Insider Activities on CADL

Follow Candel Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CADL shares.

Notify only if

Insider Trading

Get notified when an Candel Therapeutics, Inc. insider buys or sells CADL shares.

Notify only if

News

Receive news related to Candel Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on CADL